<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn></journal-meta><article-meta><article-id pub-id-type="pmid">7917910</article-id><article-id pub-id-type="pmc">2033385</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fredrikson</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hursti</surname><given-names>T. J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Steineck</surname><given-names>G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>F&#x000fc;rst</surname><given-names>C. J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>B&#x000f6;rjesson</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Peterson</surname><given-names>C.</given-names></name></contrib></contrib-group><aff>Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.</aff><pub-date pub-type="ppub"><month>10</month><year>1994</year></pub-date><volume>70</volume><issue>4</issue><fpage>642</fpage><lpage>645</lpage><abstract><p>The relation between pretreatment night-time urinary catecholamine excretion and chemotherapy-induced nausea and vomiting was studied. The first cohort included 17 women and three men with various cancer forms receiving low or moderately emetogenic chemotherapy. The second cohort included 42 women receiving cisplatinum (50 mg m-2) for ovarian cancer and ondansetron as an antiemetic (8 mg i.v. x 3 at chemotherapy and 8 mg p.o. x 3 for 5 days). Relatively higher noradrenaline, but not adrenaline, excretion was associated with an increased intensity of delayed nausea following treatment. Vomiting was not consistently related to the excretion of either catecholamine. The results indicate that noradrenaline modulates delayed nausea resulting from chemotherapy.</p></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00056-0072.tif" xlink:title="scanned-page" xlink:role="642" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00056-0073.tif" xlink:title="scanned-page" xlink:role="643" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00056-0074.tif" xlink:title="scanned-page" xlink:role="644" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00056-0075.tif" xlink:title="scanned-page" xlink:role="645" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

